Gilead Sciences Wins FDA Approval for HIV Pill Bixlenvo
MT newswire2026/08/27 23:36Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
07:36 PM EDT, 08/27/2026 (MT Newswires) -- Gilead Sciences (GILD) said on Thursday the US Food and Drug Administration approved BixlenvoTM, bictegravir/lenacapavir, the first once-daily single tablet regimen for adults with HIV who are virologically suppressed, meaning their virus is controlled. The pill combines bictegravir, an integrase inhibitor that blocks HIV replication with a high resistance barrier, and lenacapavir, a capsid inhibitor that targets the virus's protective shell with no cross-resistance to other drugs, the company said. Approval was based on Phase 3 ARTISTRY trials showing maintained viral suppression at Week 48, with common side-effects including headache, nausea and diarrhea, according to the company. Gilead said Bixlenvo is designed for patients on complex regimens who cannot take existing STRs, offering a simplified daily option.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Invex says unaware of cause behind FIDEAL 20’s 20.45% price drop on unusual trading
Reuters•2026/08/30 16:22

Trump: Will Refill U.S. Strategic Reserves with Venezuelan Oil
金色财经•2026/08/30 15:33
Crypto prices
MoreBitcoin
BTC
$79,158.65
+1.46%
Ethereum
ETH
$2,529.04
+3.22%
Tether USDt
USDT
$0.9999
-0.01%
BNB
BNB
$703.42
+1.67%
XRP
XRP
$1.41
+1.33%
USDC
USDC
$1.0000
-0.00%
Solana
SOL
$106.68
+1.57%
TRON
TRX
$0.3405
+0.70%
Hyperliquid
HYPE
$83.63
+0.37%
Zcash
ZEC
$872.74
+4.12%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now